search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Company insight


Device validation gets a jump-start


Microspec says it is ‘setting standards’ with its JumpStart programme. Company founder and CEO Tim Steele explains what the programme is and how it can help device manufacturers get ahead of challenging and often time-consuming validation protocols.


T


he butterfly effect or not, the idea that even the smallest of issues can ultimately have substantial effects is not in doubt. In the medical device world, every element of a device is vulnerable to this. From its design and manufacture to ultimate use, small and often unintentional deviations can result in significant and sometimes dangerous consequences. That is why qualification and validation protocols are essential; the likes of installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ). “IQ documents that equipment has been installed according to the manufacturer’s specifications, is properly connected to the required utilities and operates as designed,” explains Tim Steele, founder and CEO of Microspec, an ISO 13485 contract manufacturer specialising in custom medical tubing for medical device customers. “QQ typically represents worst-case process conditions and quality outcomes.”


expertise in extrusion within the industry, Microspec engages in strategic partnerships with the customer contributing design and material input,” he continues.


Navigate complexity


Qualification and validation processes are complex, requiring significant input from all parties. However, increasingly demanding timeframes are adding to the complexities, which is why Microspec has launched its JumpStart initiative. Steele says: “It is expected, within the development of the extrusion process, to negotiate with the customer print specifications and tolerances, and to align product specifications and design intent with manufacturability and capability requirements. These negotiations are critical to the process and ensure a robust and validated process is achieved.”


During the development of the part in early phases of the project, it is important


“Being able to deliver this support, and to react quickly and adjust within aggressive timelines is critical to a successful validation programme.”


The company, founded in 1989, ran its first extrusion in 1990; it continues to do so today, serving as an industry leader with a global reputation for innovation, quality and a willingness to accept challenges. “These are complex geometries and extrusions with multiple lumens, manufactured to customer-supplied designs and specifications, and used in a variety of innovative medical devices,” says Steele. Products include extruded custom bump tubing, co-extrusions, microextrusions, multilumen tubing, profile extrusions and coated wires. “In addition to a proven


to identify and mitigate factors that pose risks to the validation. Among them is understanding and minimising sources of variation in the process or due to measurement error, defining inspection methods, evaluating process performance with multiple lots of raw materials, and understanding product normalisation. “Microspec recognised the need and the opportunity to develop the JumpStart Validation Programme to improve the validation delivery timeline needed to meet and support the aggressive customer timelines, and requirements


Medical Device Developments / www.nsmedicaldevices.com


for customer design validation (DV) builds and product launch,” Steele says. “We realised terrific gains by identifying early the intent to validate and thereby engaging the customer up front in the development of the extrusion process to leverage prototype extrusions and data, and align with validation and capability objectives and requirements.”


A new standard


The company says JumpStart is defined by discrete phases with targeted and customised activities and objectives, from prototyping and development through OQ/PQ that are intended to streamline the path to validation. The first phase, which takes between seven and 15 weeks, includes the initial feasibility extrusion, nominal process development extrusion and a quality review. Phase two runs for between five and 11 weeks and includes a tooling capability and process window study, quality review, and an internal and customer review. Finally, taking between four and eight weeks, phase three covers OQ and PQ validation.


Steele says JumpStart supports customers through validation processes and results in validated components that meet the requirements of the customer’s DV builds, master validation plan and submission, as well as their product launch. “Being able to deliver this support, and to react quickly and adjust within aggressive timelines is critical to a successful validation programme. Having the engineering expertise and technical capability to design and manufacture in-house allows Microspec to react quickly within aggressive timelines. We are setting a new standard in the industry,” Steele concludes. ●


www.microspecorporation.com 127


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170